Clinical trials
Terminated Phase 1/2 Carcinoma, Renal Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2023 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 39 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Calithera Biosciences, Inc | 2 |
| Genmab | 2 |
| 4D pharma plc | 1 |
| AHS Cancer Control Alberta | 1 |
| Apollomics (Australia) Pty. Ltd. | 1 |
| Aravive, Inc. | 1 |
| Celgene | 1 |
| City of Hope Medical Center | 1 |
| Dana-Farber Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 39 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Kidney Neoplasms | 8 |
| Melanoma | 8 |
| Neoplasm Metastasis | 8 |
| Triple Negative Breast Neoplasms | 7 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Stomach Neoplasms | 5 |
| Carcinoma, Hepatocellular | 4 |
| Carcinoma, Transitional Cell | 4 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.